NCT04836052View on ClinicalTrials.gov

Omega-3 Oil Use in COVID-19 Patients in Qatar

PHASE3UnknownINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

August 24, 2021

Study Completion Date

December 24, 2021

Conditions
COVID-19
Interventions
DRUG

Omega 3 fatty acid

omega-3-oil 2 gm twice daily PO/NGT/OGT for 28 days or ICU discharge or death.

Trial Locations (1)

3050

RECRUITING

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT04836052 - Omega-3 Oil Use in COVID-19 Patients in Qatar | Biotech Hunter | Biotech Hunter